BRPI0518399A2 - produÇço de beta-lactama - Google Patents

produÇço de beta-lactama

Info

Publication number
BRPI0518399A2
BRPI0518399A2 BRPI0518399-5A BRPI0518399A BRPI0518399A2 BR PI0518399 A2 BRPI0518399 A2 BR PI0518399A2 BR PI0518399 A BRPI0518399 A BR PI0518399A BR PI0518399 A2 BRPI0518399 A2 BR PI0518399A2
Authority
BR
Brazil
Prior art keywords
beta
lactam
production
lactam production
lactam compounds
Prior art date
Application number
BRPI0518399-5A
Other languages
English (en)
Inventor
Den Berg Marco Alexander Van
Roelof Ary Lans Bovenberg
Hendrik Jan Noorman
Bastiaan Romein
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI0518399A2 publication Critical patent/BRPI0518399A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P37/00—Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PRODUÇAO DE BETA-LACTAMA. A invenção atual descreve a transformação de um microrganismo que não produza naturalmente um composto do beta-lactam com os polinucleotídeos envolvidos no biosynthesis de compostos do beta-lactam e no uso de tais microrganismos transformados na produção de compostos do beta-lactam ou na identificação dos genes ou dos fatores envolvidos na síntese de um composto do beta-lactam.
BRPI0518399-5A 2004-12-10 2005-12-08 produÇço de beta-lactama BRPI0518399A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106471 2004-12-10
PCT/EP2005/056619 WO2006061425A2 (en) 2004-12-10 2005-12-08 Production of beta-lactam antibiotics by genetically modified non-naturally producing microorganisms

Publications (1)

Publication Number Publication Date
BRPI0518399A2 true BRPI0518399A2 (pt) 2008-11-18

Family

ID=34930032

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518399-5A BRPI0518399A2 (pt) 2004-12-10 2005-12-08 produÇço de beta-lactama

Country Status (8)

Country Link
US (1) US20080131925A1 (pt)
EP (1) EP1819813A2 (pt)
KR (1) KR20070085955A (pt)
CN (1) CN101098963A (pt)
BR (1) BRPI0518399A2 (pt)
MX (1) MX2007006780A (pt)
SG (1) SG158108A1 (pt)
WO (1) WO2006061425A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0719263A2 (pt) * 2006-10-05 2014-07-15 Dsm Ip Assets Bv Produção de antibióticos de beta-lactama
EP2080801A1 (en) * 2008-01-21 2009-07-22 Technical University of Denmark Production of non-ribosomal peptides in Saccharomyces
EP2123772A1 (en) * 2008-04-29 2009-11-25 DSM IP Assets B.V. Beta-lactam antibiotic producing strains
WO2010077806A1 (en) 2008-12-15 2010-07-08 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways
CN105132387A (zh) * 2008-12-22 2015-12-09 绿光生物科学公司 用于制造化合物的组合物和方法
US8956833B2 (en) 2010-05-07 2015-02-17 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through enzyme relocation
US8916358B2 (en) 2010-08-31 2014-12-23 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through protease manipulation
KR20150010932A (ko) 2011-09-09 2015-01-29 그린라이트 바이오사이언시스, 아이엔씨. 카바페넴의 무세포 제조법
WO2015021058A2 (en) 2013-08-05 2015-02-12 Greenlight Biosciences, Inc. Engineered proteins with a protease cleavage site
BR112017020690A2 (pt) 2015-03-30 2018-06-26 Greenlight Biosciences Inc produção livre de células de ácido ribonucleico
SG11201808721YA (en) 2016-04-06 2018-11-29 Greenlight Biosciences Inc Cell-free production of ribonucleic acid
BR112019013853A2 (pt) 2017-01-06 2020-01-28 Greenlight Biosciences Inc produção de açúcares isentos de células
JP7792196B2 (ja) 2017-10-11 2025-12-25 グリーンライト バイオサイエンシーズ インコーポレーテッド ヌクレオシド三リン酸およびリボ核酸の生成のための方法および組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327170C (en) * 1987-03-04 1994-02-22 Stephen Wyatt Queener Recombinant dna expression vectors and dna compounds that encode deacetoxycephalosporin c synthetase and deacetylcephalosporin c synthetase
GB8728811D0 (en) * 1987-12-09 1988-01-27 Beecham Group Plc Novel substance
US6258555B1 (en) * 1987-12-09 2001-07-10 Beecham Group P.L.C. DNA encoding ACV synthetase
US5882879A (en) * 1990-02-28 1999-03-16 Gist-Brocades, N.V. Method for influencing β-lactam antibiotic production and for isolation of large quantities of ACV synthetase

Also Published As

Publication number Publication date
EP1819813A2 (en) 2007-08-22
SG158108A1 (en) 2010-01-29
US20080131925A1 (en) 2008-06-05
CN101098963A (zh) 2008-01-02
MX2007006780A (es) 2007-08-06
WO2006061425A2 (en) 2006-06-15
KR20070085955A (ko) 2007-08-27
WO2006061425A3 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
IL188803A0 (en) Low ph aerated products
NO20074179L (no) Prodrugs av 2,4-pyrimidindiaminforbindelser og deres anvendelse
GT200400092A (es) Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad
BRPI0418639A (pt) inibidores de dipeptidil peptidase
BRPI0720525B8 (pt) inibidores de mapk/erk quinase
BRPI0512060A (pt) compostos orgánicos
BR0308339A (pt) Indazóis substituìdos com uma atividade anticancerosa
BRPI0606379A2 (pt) triazolftalazinas
TW200700725A (en) Detection of nucleic acid associated with disease
ECSP014105A (es) COMPUESTOS DE PIRROLO [2,3-d] PIRIMIDINA
GT200200043A (es) Nuevos compuestos antiinflamatorios de bencimidazol
ECSP088824A (es) Prolinamidas sustituidas, su preparación y su uso como medicamentos
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
MY142441A (en) Azole derivatives as inhibitors of lipases and phospholipases
BRPI0600777A (pt) método e sistema para a criação, armazenamento, gerenciamento e consumo de dados especìficos de cultura
BRPI0418450A (pt) uso de resinas endurecìveis por radiação a base de resinas de cetona e/ou uréia-aldeìdo
ATE519849T1 (de) Herstellung von pravastatin
BRPI0507894A (pt) pirazolopirimidinas
GT200300231A (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
AU2003294253A1 (en) Emulsions including surface-modified organic molecules
EA200600607A1 (ru) Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы
DE112008003640A5 (de) Verfahren zur Herstellung von 3,6-Dihydro-1,3,5-Triazin-Derivaten
BR0211903A (pt) Isoxazolopiridinonas
SG158108A1 (en) Production of beta-lactam antibiotics by genetically modified non- naturally producing microorganisms
WO2008056360A9 (en) COMPOSITION BASED ON CHICK PEAS

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.